Wspólnotowy Serwis Informacyjny Badan i Rozwoju - CORDIS

FP5

HYPERSOLUTES Streszczenie raportu

Project ID: QLK3-CT-2000-00640
Źródło dofinansowania: FP5-LIFE QUALITY
Kraj: Germany

Use of hypersolutes in pharmaceutical and cosmetic formulations

We have established an industrial production procedure for mannosylglycerate (MG) and mannosylglyceramide (MGA) and tested the usefullness of these compounds in different applications. As a result two patents have already been filed for the use of MG and MGA in cosmetic formulations and as adjuvants in vaccines.

These patents are based in the superior capabilities of these two solutes to serve as moisturising agents and as protein protective agents against thermal denaturation or/and repetitive use.

Reported by

BITOP - GESELLSCHAFT FUER BIOTECHNISCHE OPTIMIERUNG
Stockumer Straße 28
58453 WITTEN
Germany
See on map
Śledź nas na: RSS Facebook Twitter YouTube Zarządzany przez Urząd Publikacji UE W górę